|
IPO9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.65530000000502E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.32200000000505E-05 |
| Normal-vs-Stage2 |
1.103860E-03 |
| Normal-vs-Stage3 |
2.023600E-04 |
| Normal-vs-Stage4 |
3.542300E-03 |
| Stage1-vs-Stage2 |
7.188800E-01 |
| Stage1-vs-Stage3 |
7.365400E-01 |
| Stage1-vs-Stage4 |
8.421600E-01 |
| Stage2-vs-Stage3 |
9.208800E-01 |
| Stage2-vs-Stage4 |
6.608400E-01 |
| Stage3-vs-Stage4 |
6.830600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.9789999999984E-05 |
| Normal-vs-AfricanAmerican |
7.864400E-01 |
| Normal-vs-Asian |
3.242500E-03 |
| Caucasian-vs-AfricanAmerican |
9.618700E-03 |
| Caucasian-vs-Asian |
6.977800E-01 |
| AfricanAmerican-vs-Asian |
4.116300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.45440000000197E-05 |
| Normal-vs-Female |
7.7086000000004E-05 |
| Male-vs-Female |
4.891000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.375270E-04 |
| Normal-vs-Age(41-60Yrs) |
5.82109999999192E-05 |
| Normal-vs-Age(61-80Yrs) |
3.503800E-03 |
| Normal-vs-Age(81-100Yrs) |
1.295850E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.108200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.232800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.567600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.254200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.462000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.028800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.765830E-01 |
| Classical-VS-Follicular |
1.843030E-03 |
| Classical-VS-Other |
9.685600E-02 |
| Classical-VS-Normal |
1.681020E-03 |
| Tall-VS-Follicular |
5.316000E-01 |
| Tall-VS-Other |
2.955600E-01 |
| Tall-VS-Normal |
1.120710E-03 |
| Follicular-VS-Other |
5.967000E-01 |
| Follicular-VS-Normal |
4.53320000004531E-06 |
| Other-VS-Normal |
6.436300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.74383000000056E-05 |
| Normal-vs-N1 |
2.441900E-04 |
| N0-vs-N1 |
7.911000E-01 |
|
|
